Skip to main content
Equibles

MILLENNIUM MANAGEMENT LLC

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1273087 NEW YORK, NY
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$245,330 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
18 quarters on record

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Derivatives in VTGN

reported options exposure · as of Jun 30, 2026
CallValue
$70,518
CallShares
306,600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 468,410 $232,673,299
2 INSM
INSMED Inc
 2,048,005 $218,358,293
3 APGE
Apogee Therapeutics, Inc.
 1,491,404 $197,954,052
4 JAZZ
Jazz Pharmaceuticals plc
 763,880 $184,072,163
5 ONC
BeOne Medicines Ltd.
 543,323 $154,830,755
6 AXSM
Axsome Therapeutics, Inc.
 556,088 $136,113,659
7 BMRN
Biomarin Pharmaceutical Inc
 2,071,816 $118,549,311
8 REGN
Regeneron Pharmaceuticals, Inc.
 165,120 $102,958,924

All Filings in VTGN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $70,518 306,600
2026-03-31 $121,980 214,000
2026-03-31 $245,330 430,404
2025-12-31 $130,049 197,045
2025-09-30 $73,399 20,676
2024-12-31 $114,259 38,732
2024-09-30 $76,264 25,337
2024-03-31 $192,709 36,498
2023-09-30 $88,398 16,870
2023-06-30 $189,000 101,070
2022-12-31 $10,749 107,494
2022-09-30 $128,191 854,611
2022-06-30 $768,203 872,959
2022-03-31 $1,537,953 1,240,285
2021-12-31 $20,630 10,580
2021-09-30 $1,220,226 445,338
2021-06-30 $556,627 176,707
2021-03-31 $2,974,308 1,396,389
2020-12-31 $1,516,468 781,685